Product/Composition:- | Glycopyrrolate and Indacaterol |
---|---|
Strength:- | 27.5 mcg + 15.6 mcg or 85 mcg + 43 mcg |
Form:- | Subcutaneous injection |
Reference Brands:- | Utibron Neohaler(US), Ultibro Breezhaler(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Glycopyrrolate and indacaterol is a dual bronchodilator used for COPD maintenance treatment. It combines a LAMA and a LABA to improve breathing and reduce symptoms. Available as a dry powder inhaler under brands like Ultibro Breezhaler, it is taken once daily for long-term lung function support.
Glycopyrrolate and indacaterol is a fixed-dose combination used in the maintenance treatment of chronic obstructive pulmonary disease (COPD). This dual bronchodilator combines a long-acting muscarinic antagonist (LAMA) with a long-acting beta-agonist (LABA) to improve lung function and reduce COPD symptoms. Available under brand names like Ultibro Breezhaler in the EU and previously Utibron Neohaler in the US, it is delivered via dry powder inhaler (DPI) for once-daily or twice-daily use. The combination enhances airway relaxation, reduces breathlessness, and supports better respiratory control. It is not intended for asthma or acute bronchospasm relief.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications